NewLink Genetics (NLNK) Tops Q4 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
NewLink Genetics (NLNK) PT Raised to $26 at Stifel
March 1, 2017 8:35 AM ESTStifel raised its price target on NewLink Genetics (NASDAQ: NLNK) to $26.00 (from $22.00) while maintaining a Buy rating.
Analyst Stephen Willey commented, "NLNK shares are looking increasingly actionable ahead of what we believe could prove to be a transformational next 1-6 months highlighted by two... More
